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Infected cell protein (ICP) 27 is an essential herpes simplex virus type 1 (HSV-1) phosphoprotein required for optimal viral DNA and
early or late gene synthesis. Three slow-migrating immunoreactive species were detected using multiple anti-ICP27 antibodies following
HSV-1 infection of HEp-2 and Vero cells in the presence of cycloheximide (CHX). Generation of the protein triplet moieties required
transcription of the a27 gene. These forms were observed following infection with a series of recombinant viruses that produce truncated
ICP27 polypeptides, suggesting that alternative splicing is not involved in the process. These ICP27 species were not observed following
translation inhibition by puromycin (PUR). Synthesis of the triplet occurred by 6 hpi and CHX addition as late as 3 hpi still enabled their
production. That the ICP27 species were detected in uninfected ICP27-expressing cells without CHX, but not in its presence, suggests a
mechanism in which virus infection is required to produce the forms when ribosomal aminoacyl-transfer RNA (tRNA) translocation is
blocked.
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Herpes simplex virus type 1 (HSV-1) is a pathogenic
alphaherpesvirus that causes a variety of infections in
humans. During a productive lytic infection in cultured
cells, HSV-1 replication follows a highly ordered program
that involves tight transcriptional regulation that proceeds in
cascade fashion (Roizman and Knipe, 2001). HSV-1 gene
expression begins with the a, or immediate-early (IE), genes
whose transcription occurs in the absence of de novo protein
synthesis (Batterson and Roizman, 1983; Honess and Roiz-
man, 1974, 1975). The a gene products, which include
infected cell protein (ICP) 4 and 27, cooperatively act to
regulate all kinetic classes of viral gene expression (Roiz-
man and Knipe, 2001). Synthesized next are the h or early0042-6822/$ - see front matter D 2004 Elsevier Inc. All rights reserved.
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associated with viral DNA synthesis (Boehmer and Lehman,
1997). The g or late (L) gene products, such as the tegument
virion proteins (VP) 16 and 22 and the envelope glycopro-
tein C (gC), are the last set of viral proteins produced and
are principally involved in virion assembly and structure
(Batterson and Roizman, 1983; Fenwick and Walker, 1978;
Read et al., 1993). Completion of the viral replication cycle
ultimately results in the destruction of infected cells.
The a/IE protein ICP27 is a multifunctional protein that
is necessary for the generation of infectious viral progeny
(Sacks et al., 1985). It physically interacts with ICP4
(Panagiotidis et al., 1997) and is required for the transition
between the h/E and g/L phases of gene expression and thus
possesses both positive and negative regulatory activities,
acting to stimulate the expression of both E and L genes,
and downregulate IE and E gene expression at late times
during infection (Hardwicke et al., 1989; Jean et al., 2001;
McCarthy et al., 1989; Rice and Knipe, 1990; Rice et al.,
1989; Sacks et al., 1985; Samaniego et al., 1995; Sandri-
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facilitates viral DNA replication, most likely by enhancing
the expression of viral factors required for DNA synthesis
(McCarthy et al., 1989; McGregor et al., 1996; Rice and
Knipe, 1990; Samaniego et al., 1995; Uprichard and Knipe,
1996). In addition to its transcriptional regulatory functions,
ICP27’s ability to bind RNA (Brown et al., 1995; Ingram et
al., 1996; Mears and Rice, 1996) and to shuttle between the
nucleus and the cytoplasm (Mears and Rice, 1998; Phelan
and Clements, 1997; Sandri-Goldin, 1998; Soliman et al.,
1997) enable it to act posttranscriptionally to (i) modulate
pre-mRNA processing and polyadenylation efficiency
(Hann et al., 1998; McGregor et al., 1996; McLauchlan et
al., 1992; Sandri-Goldin and Mendoza, 1992), (ii) bind and
stabilize the labile 3V ends of mRNA (Brown et al., 1995),
(iii) contribute to the shutoff of host protein synthesis by
inhibiting the splicing of cellular transcripts (Hardy and
Sandri-Goldin, 1994), (iv) redistribute host splicing compo-
nents (Phelan et al., 1993; Sandri-Goldin et al., 1995), and
(v) induce the nuclear retention of intron-containing tran-
scripts (Phelan et al., 1996) while participating in the export
of viral intronless transcripts (Phelan and Clements, 1997;
Sandri-Goldin, 1998; Soliman et al., 1997).
ICP27 contains 512 amino acids and has an apparent
molecular weight of 63000 (Ackermann et al., 1984). The
amino (N)-terminal end of ICP27 contains an acidic domain
(Rice et al., 1993), wherein lies a leucine-rich nuclear export
signal, NES (Sandri-Goldin, 1998). A nuclear localization
signal (NLS), nucleolar localization signal (NuLS), and an
RGG box RNA-binding motif are also located in the N-
terminal portion of ICP27 and contribute to the efficient
nuclear localization of the protein (Hibbard and Sandri-
Goldin, 1995; Mears and Rice, 1996; Mears et al., 1995;
Sandri-Goldin, 1998). Numerous studies indicate that the
carboxyl (C)-terminal half of ICP27 contains activation and
repression domains (Hardwicke et al., 1989) and is thus
required for its regulatory functions (Brown et al., 1995;
Hardwicke et al., 1989; McMahan and Schaffer, 1990; Rice
and Knipe, 1990; Rice and Lam, 1994; Soliman and Silver-
stein, 2000a, 2000b). This region of the protein also con-
tains a cysteine–histidine zinc-finger-like domain required
for ICP27’s ability to impair host cell splicing (Hardwicke
and Sandri-Goldin, 1994; Hardy and Sandri-Goldin, 1994;
Vaughan et al., 1992).
The ICP27 protein undergoes multiple posttranslational
modifications, including serine phosphorylation (Zhi and
Sandri-Goldin, 1999), methylation of arginine residues
within the RGG box (Mears and Rice, 1996), and nucleoti-
dylylation (Blaho et al., 1993, 1994). It was shown in
previous studies that two species of ICP27 are resolved by
standard sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE), although up to five species, differing
with respect to charge, are observed following two-dimen-
sional electrophoresis (Ackermann et al., 1984; Pereira et al.,
1977). Here, we report that in the presence of the ribosomal
peptidyl-tRNA translocation inhibitor cycloheximide(CHX), three unexpected protein entities were detected in
HSV-1-infected cells that reacted with anti-ICP27 antibod-
ies. These immunoreactive species were independent of the
cell lines or HSV-1 strains tested. The ICP27 entities did not
originate from incoming protein or RNA molecules as they
were not observed following infection with UV-irradiated
virus or an ICP27-null virus. The ICP27 triplet immunore-
activity pattern was not observed following infection with
wild-type HSV-1 viruses in the presence of actinomycin D
(Act. D) or with a VP16 transactivation domain mutant
virus, suggesting that viral transcription is required for the
generation of the species. Kinetic studies indicated that the
production of these ICP27 moieties were detected as early as
6 hpi following HSV-1 infection when protein synthesis was
inhibited. Termination of translation as late as 3 hpi still
enabled the generation of the ICP27 entities. Finally, the
unique ICP27 immunoreactive species were not observed
following translation inhibition by puromycin (PUR). How-
ever, the addition of cycloheximide in conjunction with
puromycin resulted in their generation, confirming that
cycloheximide has a dominant effect. Together, our results
imply that the ICP27 triplet entities are produced during
HSV-1 infection and we hypothesize that they may partake
in its regulatory activities.Results
Detection of ICP27 immunoreactive species following
HSV-1-infection in the presence of cycloheximide
During the course of studying HSV-1 infection when
protein synthesis is inhibited, we previously noted what
appeared to be protein moieties that reacted with the anti-
ICP27 antibody H1113 (Sanfilippo et al., 2004). To examine
this phenomenon more closely, we performed a series of
three experiments using the translation inhibitor cyclohex-
imide (CHX), which inhibits the peptidyl-tRNA transferase
activity of the 60S ribosomal subunit (Baliga et al., 1969).
In the first portion of this study, HEp-2 cell monolayers
were mock-infected or infected with 5 plaque forming units
(PFU) per cell of HSV-1(KOS1.1), termed KOS1.1, in the
absence or presence of 10 Ag/ml of CHX. Whole-cell
extracts were prepared at 24 hpi, separated in a denaturing
gel, transferred to nitrocellulose, and probed with anti-ICP4,
-gC, -ICP27 H1113, and -VP22 antibodies. The results of
this experiment are presented in Fig. 1.
No viral proteins were detected in mock-infected cells
(Fig. 1, lanes 1 and 2), as expected. In the absence of CHX,
high levels of the viral proteins ICP4, gC, ICP27, and VP22
were detected in cells infected with KOS1.1 (Fig. 1, lane 3).
In KOS1.1-infected cells treated with CHX, no ICP4 or gC
was detected; however, low levels of three distinct slow-
migrating protein species reacted with the anti-ICP27
H1113 mAb (Fig. 1, lane 4). These moieties were present
in relatively equal quantities, with the fastest-migrating
Fig. 1. Immunoblot detection of the viral proteins ICP4, gC, ICP27, and
VP22 in infected HEp-2 cells. Whole-cell extracts were prepared at 24 hpi
from mock-infected cells or cells infected with HSV-1(KOS1.1) in the
absence () or presence (+) of 10 Ag/ml of CHX, separated in a 15%
denaturing gel, transferred to nitrocellulose, and probed with anti-ICP4, -gC,
-ICP27 H1113 mAbs, and anti-VP22 pAb as described in Materials and
methods.
Fig. 2. Immunoblot detection of ICP27 immunoreactive species in infected
HEp-2 (A) and Vero (B) cells. Whole-cell extracts were prepared at 24 hpi
from mock-infected cells or cells infected with HSV-1(KOS1.1) or HSV-
1(F) in the absence () or presence (+) of 10 Ag/ml of CHX, separated in a
15% (A) or 12% (B) denaturing gel, transferred to nitrocellulose, and
probed with the anti-ICP27 H1113 mAb as described in Materials and
methods.
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weight of 63000) from KOS1.1 in the absence of CHX
(Fig. 1, compare lane 4 with 3). The absence of these
species in mock-infected cells argues against the possibility
that this phenomenon is due to the presence of cellular
proteins that contain the epitope for the H1113 mAb.
Additionally, slight but detectable amounts of VP22 were
observed in the KOS1.1-infected cells in the presence of
CHX (Fig. 1, lane 4), which likely reflects incoming
tegument protein and serves as a convenient positive marker
of infection, consistent with previous results (Sanfilippo et
al., 2004). These results demonstrate the existence of three
ICP27 immunoreactive species following KOS1.1 infection
in the presence of CHX and corroborate our earlier prelim-
inary data (Sanfilippo et al., 2004).
The second set of experiments was designed to investi-
gate whether these ICP27 immunoreactive bands are unique
to either the KOS1.1 strain or to the HEp-2 cell line used in
Fig. 1. Monolayer cultures of human HEp-2 and nonhuman
Vero cells were mock-infected or infected with 5 PFU per
cell of the wild-type virus strains HSV-1(KOS1.1) or HSV-
1(F) in the absence or presence of 10 Ag/ml of CHX. The
cells were harvested at 24 hpi, separated in denaturing gels,
transferred to nitrocellulose, and probed with the anti-ICP27
H1113 mAb. The results of this study (Fig. 2) were as
follows. Comparable levels of ICP27 were detected in both
KOS1.1- and HSV-1(F)-infected HEp-2 cells in the absence
of CHX (Fig. 2A, lanes 3 and 5). HEp-2 cells infected with
HSV-1(F) in the presence of CHX exhibited the same ICP27
immunoreactive pattern seen with KOS1.1 under the same
infection conditions (Fig. 2A, compare lanes 6 and 4),
indicating that the appearance of these ICP27 species is
not strain-dependent. Similarly, Vero cells infected withboth KOS1.1 and HSV-1(F) synthesized high amounts of
wild-type ICP27 protein in the absence of CHX (Fig. 2B,
lanes 3 and 5) and the three ICP27 species were detected
upon infection with both strains in the presence of CHX
(Fig. 2B, lanes 4 and 6). However, the distribution of these
entities in Vero cells varied somewhat from those seen in
HEp-2 cells (compare lane 4 in Panel 2A and 2B). In Vero
cells, the bands were not present in similar quantities as they
were in Hep-2 cells, but gradually increased in intensity
from the slowest-migrating band to the fastest-migrating
band. The variation between the patterns observed in HEp-2
and Vero cells suggests that some aspect of the cellular
protein processing machinery may be involved in the
appearance of these protein species and it may differ
between cell types. Nevertheless, because these ICP27
immunoreactivity species was also detected in Vero cells,
we conclude that the generation of these forms is not cell-
type-dependent.
In the last part of this study (Fig. 3), we set out to establish
whether these species are indeed ICP27-derived. We were
also interested in characterizing the dependence of their
formation on the concentration of CHX used in the study.
To this end, HEp-2 cells were mock-infected or infected with
KOS1.1 in the absence or presence of 5, 10, 15, or 20 Ag/ml
of CHX. At 24 hpi, whole-cell extracts were prepared,
separated on denaturing gels, transferred to nitrocellulose,
and probed with the anti-ICP27 H1113 and H1119 mAbs and
the anti-ICP27 pAb. With the H1113 mAb, the ICP27
immunoreactive entities were observed in relatively equal
quantities, regardless of the concentration of CHX used (Fig.
3A, lanes 3–6). In contrast, the two slowest-migrating
species did not react with the H1119 mAb, and instead, one
unique band was detected at all CHX concentrations (Fig.
3B, lanes 3–6). This immunoreactive pattern likely reflects
the specificity of the H1119 mAb because all three species
were detected with the anti-ICP27 pAb (Fig. 3C, lanes 3–6).
Together, these data confirm the identity of these species as
ICP27 protein. In addition, they exclude the possibility that
Fig. 4. Immunoblot detection of ICP27 immunoreactive species in infected
HEp-2 cells. Whole-cell extracts were prepared at 24 hpi from mock-
infected cells or cells infected with HSV-1(KOS1.1), UV-treated KOS1.1
(A), or vBSD27 (B) in the absence () or presence (+) of 10 Ag/ml of CHX,
separated in a 15% denaturing gel, transferred to nitrocellulose, and probed
with the anti-ICP27 H1113 mAb as described in Materials and methods.
Fig. 3. Immunoblot detection of ICP27 immunoreactive species in infected
HEp-2 cells. Whole-cell extracts were prepared at 24 hpi from mock-
infected cells or cells infected with HSV-1(KOS1.1) in the absence () or
presence of 5, 10, 15, or 20 Ag/ml of CHX, separated in a 15% (A and C) or
12% (B) denaturing gel, transferred to nitrocellulose, and probed with anti-
ICP27 H1113 mAb (A), anti-ICP27 H1119 mAb (B), and anti-ICP27 pAb
(C) as described in Materials and methods.
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consequence of the H1113 mAb used in those studies.
The ICP27 immunoreactive species are not virion derived
The results from Figs. 1–3 demonstrate that three ICP27
immunoreactive species are detected in cells upon wild-type
HSV-1 infection with CHX treatment. As shown above, the
appearance of these entities was not strain- or cell-type-
dependent and was not the result of a unique specificity of a
single primary antibody. After determining that these moi-
eties were indeed of viral origin, we next set out to
determine whether these ICP27 protein species might be
present in the incoming virion particle. To investigate this
possibility, we made use of UV-inactivated KOS1.1 virus
(Sanfilippo et al., 2004). HEp-2 cells were mock-infected or
infected with 20 PFU per cell of untreated or UV-treated
KOS1.1 in the absence or presence of 10 Ag/ml of CHX.
Whole-cell extracts were prepared at 24 hpi, separated in a
denaturing gel, transferred to nitrocellulose, and probed with
the anti-ICP27 H1113 mAb. As shown in Fig. 4A, the three
ICP27 immunoreactive entities were detected upon KOS1.1
infection in the presence of CHX (Fig. 4A, lane 3).
However, no ICP27 species were observed at all following
infection with UV-irradiated KOS1.1, regardless of CHX
treatment (Fig. 4A, lanes 5 and 6). This finding indicates
that the ICP27 protein moieties observed in KOS1.1-
infected cells with CHX are not packaged within or derived
from incoming HSV-1 virus particles. UV inactivation
knocked out all expression of ICP27. Because UV inacti-
vation of infectivity has a much larger target size than
expression of ICP27, this result indicates that the genome
took a large number of hits, as we had hoped.We then set out to determine whether these ICP27 species
are encoded by viral RNAs that might possibly have become
packaged in the virion particle. Such RNAs, if they exist,
may have been damaged upon exposure to UV light.
However, such molecules should be present in virions of
the ICP27-null virus vBSD27 (Soliman et al., 1997), as this
virus is grown on complementing cells and produces essen-
tially wild-type levels of ICP27 in the Vero 2.2s (Sekulovich
et al., 1988). To address this possibility, HEp-2 cells were
mock-infected or infected with 5 PFU per cell of KOS1.1 or
vBSD27 in the absence or presence of 10 Ag/ml of CHX.
Whole-cell extracts were prepared at 24 hpi, separated in a
denaturing gel, transferred to nitrocellulose, and probed with
the anti-ICP27 H1113 mAb. The results of this experiment
(Fig. 4B) show that in contrast to KOS1.1 infection in the
presence of CHX, no ICP27 immunoreactive entities were
observed upon infection with vBSD27 (Fig. 4B, compare
lanes 5 and 6 with 4). These data support the results obtained
in Fig. 4A and demonstrate that neither incoming virion
ICP27 proteins nor RNA molecules are responsible for the
appearance of these ICP27 immunoreactive species.
The generation of ICP27 immunoreactive species requires
viral transcription
The results presented in Fig. 4 led us to propose that the
production of these ICP27 immunoreactive entities might
involve transcription of the a27 gene from incoming viral
DNA. To test this hypothesis, we performed a set of two
experiments designed to decrease (knock-down) HSV-1
gene expression. In the first portion, we made use of the
recombinant virus HSV-1(V422), termed V422, which con-
tains a truncation in the C-terminal acidic transcriptional
activation domain of VP16 (Lam et al., 1996). As described
previously, this VP16 defect can be largely overcome by the
addition of hexamethylene bisacetamide (HMBA) to the
culture medium (Smiley and Duncan, 1997). The mecha-
nism of HMBA action is not fully understood, yet it is
thought that this drug promotes the progression of cells into
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active, and its presence thus results in an increase in HSV-1
IE RNA accumulation (McFarlane et al., 1992). HEp-2 cell
monolayers were infected with 10 PFU per cell of KOS1.1
or V422 in the absence, presence, and combination of 10
Ag/ml of CHX or 3 mM HMBA. At 24 hpi, whole-cell
extracts were prepared, separated on a denaturing gel,
transferred to nitrocellulose and probed with anti-ICP4,
anti-gC, and anti-ICP27 H1113 mAbs. The results (Fig.
5A) of this experiment were as follows.
High levels of ICP4, gC, and ICP27 were produced in
cells infected with KOS1.1 in the absence of CHX and their
respective levels did not significantly increase in the pres-
ence of HMBA (Fig. 5A, lanes 8 and 2). As expected (Lam
et al., 1996), V422-infected cells synthesized reduced levels
of viral proteins compared to KOS1.1 in the absence of
CHX (Fig. 5A, compare lanes 6 and 8), but treatment with
HMBA resulted in a considerable increase in the amounts of
ICP4, gC, and ICP27 (Fig. 5A, lane 4). When CHX was
present, little to no ICP4 or gC was detected in cells infected
with KOS1.1 or V422 (Fig. 5A, lanes 7 and 5), even upon
HMBA addition (Fig. 5A, lanes 1 and 3). Following
treatment with CHX, the ICP27 immunoreactive species
were detected in KOS1.1-infected cells in both the absence
and presence of HMBA (Fig. 5A, lanes 7 and 1). Although
this ICP27 pattern was not observed in cells infected with
V422 in the presence of CHX (Fig. 5A, lane 5), theFig. 5. (A) Immunoblot detection of the viral proteins ICP4, gC, and ICP27
in infected HEp-2 cells. Whole-cell extracts were prepared at 24 hpi from
cells infected with HSV-1(KOS1.1) or HSV-1(V422) in the absence () or
presence (+) of 10 Ag/ml of CHX or 3 mM HMBA, separated in a 15%
denaturing gel, transferred to nitrocellulose, and probed with anti-ICP4, -gC,
and -ICP27 H1113 mAbs as described in Materials and methods. (B)
Immunoblot detection of ICP27 immunoreactive species in infected HEp-2
cells. Whole-cell extracts were prepared at 24 hpi from HSV-1(KOS1.1)-
infected cells in the absence () or presence (+) of 10 Ag/ml of CHX, 125
ng/ml of Act. D, or 125 nl/ml of DMSO, separated in a 15% denaturing gel,
transferred to nitrocellulose, and probed with the anti-ICP27 pAb as
described in Materials and methods.combination of HMBA with CHX in V422-infected cells
resulted in detection of these ICP27 species (Fig. 5A, lane
3). These findings suggest that the increase in transcription
due to HMBA treatment is responsible for the observance of
the ICP27 immunoreactive entities.
In the second part of this experiment, we set out to
determine whether the production of these ICP27 species
requires active transcription by utilizing the inhibitor acti-
nomycin D (Act. D). HEp-2 cells were infected with 5 PFU
per cell of KOS1.1 or vBSD27 in the absence, presence, and
combination of 10 Ag/ml of CHX and 125 ng/ml of Act. D.
As a control, 125 nl/ml of dimethylsulfoxide (DMSO)
solvent was also tested. Whole-cell extracts were prepared
at 24 hpi, separated in a denaturing gel, transferred to
nitrocellulose, and probed with the anti-ICP27 H1113
pAb. The results of this experiment are presented in Fig.
5B. Although KOS1.1-infected cells synthesized high levels
of the 63000 molecular weight ICP27 protein in the absence
of CHX (lane 1), only minimal amounts of the ICP27
protein were observed in cells infected with KOS1.1 in
the presence of Act. D (Fig. 5B, lane 3). The three slow-
migrating ICP27 moieties were detected in KOS1.1.-
infected cells upon CHX treatment, yet were not observed
when Act. D was combined with CHX (Fig. 5B, compare
lanes 4 with 6). The levels of ICP27 protein detected
following KOS1.1 infection upon DMSO treatment were
slightly increased compared to the amounts seen in its
absence, most notably in the presence of CHX (Fig. 5B,
compare lanes 2 and 5 with 1 and 4). This result is
consistent with previous studies, which indicate that DMSO
enhances HSV-1 IE RNA accumulation (McFarlane et al.,
1992). Thus, these data indicate that the ICP27 immunore-
active species are not observed when transcription is im-
paired. From these results, we conclude that the generation
of these ICP27 immunoreactive species requires transcrip-
tion. Taken together, these results suggest that in HSV-1-
infected cells in the presence of CHX, ICP27 is transcribed
and subsequently translated.
The ICP27 triplet is not derived from alternative splicing
One possible explanation for this phenomenon is that
each ICP27 band is generated by some form of alternative
mRNA splicing. To test this, we utilized a series of recom-
binant viruses that contain either deletion or stop-codon
insertion mutations across the body of the ICP27 gene
(Aubert et al., 2001; Mears and Rice, 1996; Mears et al.,
1995; Rice and Knipe, 1990). HEp-2 cells were infected in
the presence or absence of CHX with the following viruses:
KOS1.1, d3–4, d4–5, d5–6, d6–7, n263R, and n406R.
Whole-cell extracts were prepared at 24 hpi, separated in a
denaturing gel, transferred to nitrocellulose, and probed with
the ICP27 pAb (Fig. 6). With the exception of the low levels
of ICP27 that detected following infection with the n263R
virus (Fig. 6B, lane 3), large amounts of ICP27 were
detected with all viruses in the absence of CHX (Figs. 6A
Fig. 6. Immunoblot detection of ICP27 immunoreactive species in infected
HEp-2 cells. Whole-cell extracts were prepared at 24 hpi from mock-
infected cells or cells infected with ICP27 deletion mutants d3–4, d4–5,
d5–6, or d6–7 (A) or stop-codon insertion mutants n263R or n406R (B) in
the absence () or presence (+) of 10 Ag/ml of CHX, separated in a 15%
denaturing gel, transferred to nitrocellulose, and probed with the anti-ICP27
pAb as described in Materials and methods.
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observations (Aubert et al., 2001). Regardless of the mutat-
ed ICP27 protein synthesized, the three immunoreactive
forms were observed with each recombinant virus in the
presence of CHX, similar to those observed following wild-
type KOS1.1 infection under the same conditions (Figs. 6A
and B, even-numbered lanes). Close inspection of all non-
treated, infected cells in Fig. 6 revealed that at least two faint
low mobility species could be observed that seemed to
migrate at similar positions as the forms detected in the
presence of CHX (e.g., Fig. 6A, compare lane 5 and 6). It
should be noted that because these mutated ICP27 proteins
contained deletions and truncations, they all migrated below
(faster than) the wild-type ICP27. Based on these results, we
conclude that alternative splicing is not the cause of theFig. 7. Immunoblot detection of ICP27 immunoreactive species in infected HEp-2
infected cells or at 3, 6, 9, or 24 hpi from cells infected with HSV-1(KOS1.1)
denaturing gel, transferred to nitrocellulose, and probed with the anti-ICP27 pAb a
prepared at 24 hpi from mock-infected cells or at 3, 6, 9, or 24 hpi from cells infect
added at 0, 3, 6, or 9 hpi, separated in a 15% denaturing gel, transferred to nitroc
methods.generation of the ICP27 triplet forms because they are
produced with six separate mutant forms of the protein. It
is unlikely that this combination of mutated genes would
maintain the required number of splice-donor and splice-
acceptor sites to consistently yield triplets in all six cases.
Synthesis of ICP27 species initiates between 3 and 6 h post
infection
The data presented thus far involved detection of ICP27
species at 24 hpi. To investigate the kinetics of their
production during HSV-1 infection, we performed two
experiments in which we varied the times of either whole-
cell extract preparation or CHX addition during infection. In
the first part of this study, we were interested in determining
the earliest time point in which these ICP27 species could be
observed. HEp-2 cell monolayers were mock-infected or
infected with 5 PFU per cell of KOS1.1 in the absence or
presence of 10 Ag/ml of CHX. Whole-cell extracts were
prepared at 3, 6, 9, and 24 hpi, separated in a denaturing gel,
transferred to nitrocellulose, and probed with the anti-ICP27
pAb. The results (Fig. 7A) of this experiment are as follows.
Without CHX treatment, low amounts of the 63000 molec-
ular weight ICP27 protein were detected at 3 hpi in cells
infected with KOS1.1 (Fig. 7A, lane 3), consistent with the
synthesis of ICP27 as an IE gene product. By 6 hpi, levels of
the 63000 molecular weight ICP27 increased significantly
in KOS1.1-infected cells and accumulated to their highest
levels by 24 hpi in the absence of CHX (Fig. 7A, lanes 5, 7,
and 9). In the presence of CHX, the triplet ICP27 moieties
were detected in cells infected with KOS1.1 at 6 but not 3
hpi (Fig. 7A, compare lanes 6 with 4). The amount of these
entities in CHX treated KOS1.1-infected cells increased at 9
hpi and was most abundant at 24 hpi (Fig. 7A, lanes 8 and
10). As above (Fig. 6), the nontreated, KOS1.1-infected
cells had two faint low mobility species that could be
observed above the predominant canonical 63000 molecularcells. (A) Whole-cell extracts (WCX) were prepared at 24 hpi from mock-
in the absence () or presence of 10 Ag/ml of CHX, separated in a 15%
s described in Materials and methods. (B) Whole-cell extracts (WCX) were
ed with HSV-1(KOS1.1) in the absence () or presence of 10 Ag/ml of CHX
ellulose, and probed with the anti-ICP27 pAb as described in Materials and
Fig. 8. Immunoblot detection of the viral proteins ICP4 and ICP27 in
infected HEp-2 cells. Whole-cell extracts were prepared at 24 hpi from
HSV-1(KOS1.1)-infected cells in the absence () or presence of 5 or 10 Ag/
ml of CHX, or 0.5 or 1 Ag/ml of PUR, separated in a 15% denaturing gel,
transferred to nitrocellulose, and probed with the anti-ICP27 pAb as
described in Materials and methods.
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to migrate at similar positions as the forms detected in the
presence of CHX at 6, 9, and 24 hpi. These results indicate
that translation of the ICP27 triplet species occurred by
6 hpi.
In the second portion of this experiment, we set out to
determine the latest time that CHX could be added during
infection and still yield the ICP27 triplet species. Monolayer
HEp-2 cultures were mock-infected or infected with 5 PFU
per cell of KOS1.1 and at 0, 3, 6, 9 hpi, 10 Ag/ml of CHX
was added to the medium and maintained until 24 hpi. Each
infection was performed in duplicate. One set was used to
make cell extracts at each time of CHX addition. In the
second set, CHX was added at each designated time point
and maintained to 24 hpi. Thus, whole-cell extracts were
prepared at 3, 6, 9, and 24 hpi, separated in a denaturing gel,
transferred to nitrocellulose, and probed with the anti-ICP27
pAb. The results are presented in Fig. 7B. In the absence of
CHX, KOS1.1-infected cells progressively synthesized in-
creasing amounts of the 63000 molecular weight ICP27
protein between 3 and 24 hpi (Fig. 7B, lanes 4, 6, 8, and 10),
consistent with the data presented in Fig. 7A. When CHX
was added at 9 hpi, we detected levels of ICP27 protein
comparable to that seen in cells infected with KOS1.1 for 9
hpi in the absence of CHX (Fig. 7B, compare lanes 7 and 8).
Slow-migrating ICP27 immunoreactive species were clearly
detected in cells infected with KOS1.1 when CHX was
added at either 0 or 3 hpi (Fig. 7B, lanes 9 and 3). Faint
slow-migrating ICP27 species were detected in KOS1.1-
infected cells with CHX addition at 6 hpi but were somewhat
occluded by the presence of the 63000 molecular weight
ICP27 protein (Fig. 7B, compare lanes 6 with 9 and 3).
These results, together with the data presented in Fig. 7A,
suggest that these ICP27 species are sufficiently synthesized
to the point that they can be readily detected at 6 hpi. Based
on these observations, we conclude that these forms are
produced during standard, inhibitor-free HSV-1 infection.
Our addition of CHX, added as late as 3 hpi, effectively
blocks the synthesis of the 63000 molecular weight ICP27
protein, thus revealing these otherwise hidden forms.
ICP27 species detected when ribosomal peptidyl-tRNA
translocation is inhibited during infection
The goal of this next study was to gain insight into the
mechanism of translation of the ICP27 triplet. Because all of
the previous data utilized CHX, we set out to investigate
HSV-1 infection in the presence of the translation inhibitor
puromycin (PUR), which acts through a mechanism diffe-
rent from that of CHX. PUR acts as an analogue of amino-
acyl transfer RNA (tRNA), causing premature chain
termination of nascent polypeptides (Allen and Zamecnik,
1962; Morris and Schweet, 1961). HEp-2 cell monolayers
were infected with 5 PFU per cell of KOS1.1 in the absence,
presence, or combination of 5 or 10 Ag/ml of CHX and 0.5
or 1 Ag/ml of PUR. Whole-cell extracts were prepared at 24hpi, separated in a denaturing gel, transferred to nitrocellu-
lose, and probed with the anti-ICP4 mAb and the anti-ICP27
pAb. The results (Fig. 8) showed that (i) control cells
infected with KOS1.1 in the absence of both CHX and
PUR synthesized high levels of both ICP4 and ICP27 (Fig.
8, lane 1) and (ii) in KOS1.1-infected cells treated with 10
Ag/ml of CHX, no ICP4 was synthesized, yet the three
ICP27 immunoreactive species were observed (Fig. 8, lane
2). Upon treatment of KOS1.1-infected cells with 0.5 Ag/ml
of PUR, we observed reduced amounts of ICP4 and ICP27
compared to those seen in untreated cells (Fig. 8, compare
lane 3 with 1), indicating the efficacy of this dose of the
drug. Under these conditions, no slow-migrating ICP27
entities were detected (Fig. 8, lane 3). Treatment of infected
cells with 0.5 Ag/ml of PUR in conjunction with 5 Ag/ml of
CHX resulted in a further reduction in the levels of ICP4
compared to that with 0.5 Ag/ml of PUR alone (Fig. 8,
compare lane 4 with 3). In addition, this combination
yielded the unmistakable detection of the three slow-
migrating ICP27 moieties (Fig. 8, lane 4). When KOS1.1-
infected cells were treated with 1 Ag/ml of PUR, we still
observed minimal amounts of both ICP4 and the 63000
molecular weight ICP27 protein, but not the ICP27 triplet
species (Fig. 8, lane 5). In contrast, the combination of 1 Ag/
ml of PUR and 10 Ag/ml of CHX resulted in the complete
inhibition of ICP4 synthesis and the generation of the ICP27
triplet moieties (Fig. 8, compare lane 6 with 5). These data
indicate that although PUR is able to inhibit the synthesis of
the ICP27 immunoreactive entities, treatment with PUR in
conjunction with CHX yields the triplet species suggesting
CHX exerts a dominant effect over PUR.
ICP27 species detected in the absence of viral infection
Finally, it was our desire to determine whether the
production of these ICP27 entities requires other viral
components. Thus, we made use of the Vero 2.2 cell line,
which is a stably transfected Vero-derived cell line express-
ing ICP27 under its own promoter (Sekulovich et al., 1988).
Vero 2.2 cell monolayers were mock-infected or infected
with 5 PFU per cell of vBSD27 in the absence or presence
of 10 Ag/ml of CHX. Whole-cell extracts were prepared at
24 hpi, separated in a denaturing gel, transferred to nitro-
Fig. 9. Immunoblot detection of ICP27 immunoreactive species in infected
Vero 2.2 cells. Whole-cell extracts were prepared at 24 hpi from mock-
infected cells or cells infected with vBSD27 in the absence () or presence
(+) of 10 Ag/ml of CHX, separated in a 15% denaturing gel, transferred to
nitrocellulose, and probed with the anti-ICP27 pAb as described in
Materials and methods.
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Cells infected with vBSD27 in the absence of CHX synthe-
sized high levels of the 63000 molecular weight ICP27
protein, as expected, because the ICP27 deletion contained
in this virus is complemented on Vero 2.2 cells (Fig. 9, lane
3). Following CHX treatment, we detected ICP27 immuno-
reactive forms in vBSD27-infected cells (Fig. 9, lane 4). The
distribution of these forms had a similar pattern as that
observed in infected Vero cells under the same conditions
(Fig. 2B, lane 4). We observed faint but detectable ICP27
species, which migrated slower than the 63000 molecular
weight ICP27 protein, in mock-infected cells without CHX
treatment (Fig. 9, compare lane 1 with 3). In contrast, these
ICP27 entities were not detected in mock-infected cells
treated with CHX (Fig. 9, lane 2). This result implies that
these ICP27 forms are produced in the absence of other viral
encoded or induced factors. The inability to detect these
forms in the presence of CHX suggests that a viral factor is
required for their production when ribosomal peptidyl-
tRNA translocation is inhibited.Discussion
In previous studies, we noticed that during HSV-1
infection of human HEp-2 cells in the presence of CHX,
unexpected protein moieties reacted with the anti-ICP27
H1113 mAb (Sanfilippo et al., 2004). The goal of this study
was to define these entities and determine the requirements
for their appearance. To this end, we utilized (i) different
wild-type virus strains and mammalian cell types, (ii) three
separate anti-ICP27 antibodies, (iii) UV-inactivated HSV-1,
(iv) HSV-1 ICP27 deletion viruses, (v) a VP16 transactiva-
tion domain mutant HSV-1 virus, (vi) the transcription
inhibitor Act. D, (vii) the protein synthesis inhibitors CHX
and PUR, and (viii) a cell line expressing ICP27 as tools to
investigate these ICP27 species during HSV-1 infection.
The significant findings of our study may be summarized as
follows.
(i) Three slow-migrating ICP27 immunoreactive species
are detected during HSV-1 infection of HEp-2 and Vero
cells in the presence of CHX. The moieties reacted with
three separate antibodies, confirming that they truly wereICP27-derived, under conditions in which no ICP4 or gC
were synthesized. Their appearance was not wild-type virus
strain- or cell-type-dependent suggesting that they reflect a
feature common to all HSV-1. Interestingly, although three
species were detected with the anti-ICP27 H1113 mAb and
the pAb, the two slowest-migrating forms did not react with
the H1119 mAb, which is specific for the first 11 residues of
the protein (Mears et al., 1995; Upton et al., 1994). As the
N-terminal half of the ICP27 protein is the site of phos-
phorylation (Zhi and Sandri-Goldin, 1999), methylation
(Mears and Rice, 1996), and nucleotidylylation (Blaho et
al., 1993, 1994), it is conceivable that the two slowest-
migrating ICP27 species may contain such posttranslational
modifications that may mask the H1119 mAb epitope.
Studies are currently underway to address this possibility.
Because the forms were consistently observed as a triplet
using anti-ICP27 antibodies, it seems unlikely that they
represent ubiquitinylated species.
It is also possible that a portion of the H1119 mAb
epitope, or the epitope in its entirety, may be absent in these
two slowest-migrating entities. This situation might occur if
translation initiated at a downstream methionine, such as the
AUG found at codon 7. The resultant protein would lack the
first 6 amino acids, approximately half of the H1119 mAb
epitope, thus, potentially explaining the loss of reactivity
with this mAb. If this were the case, one would expect that
such a truncated ICP27 protein would migrate faster in
SDS-PAGE than that seen during wild-type infection. It is
important to note that the band that we have been referring
to as the standard 63000 molecular weight ICP27 is in fact a
doublet that can be resolved under certain electrophoretic
conditions (Blaho et al., 1993). It is conceivable that the
faster form in the doublet is actually a truncated ICP27
protein. The fact that all of the ICP27-mutant viruses that
were tested contain this potential second initiation site and
produced the triplet pattern is consistent with this model.
(ii) Generation of the ICP27 protein triplet moieties
requires transcription. This conclusion is based on the
findings that following infection with UV-irradiated virus,
an ICP27-null virus, a VP16 transactivation domain mutant
in the absence of HMBA, or wild-type virus in the presence
of Act. D, the ICP27 triplet species were not observed. As
stated previously, both HMBA and DMSO increase HSV-1
IE RNA production (McFarlane et al., 1992). Additionally,
the translation inhibitor CHX has also been shown to
stimulate expression from HSV-1 IE promoters, specifically
those that control synthesis of ICP0 and ICP27, and this
activation most likely occurs through an increase in mRNA
production rather than in intracellular mRNA stability
(Preston et al., 1998). This knowledge led us to speculate
that the concentration of CHX initially used in this study, 10
Ag/ml, might not have been sufficient to fully inhibit
translation in lieu of this increased ICP27 mRNA accumu-
lation. However, our observation that the forms remain
stable with increasing amounts of CHX seems to argue
against this. Thus, it seems unlikely that such an altered
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ICP27 species would arise only if their appearance was a
result of CHX inefficiency. However, it should be noted that
CHX has been shown to activate many cellular signal
transduction pathways, including those that involve c-Jun,
stress-activated protein kinase (SAPK, also known as c-Jun
N-terminal kinase), and c-Fos (Edwards and Mahadevan,
1992; Kyriakis et al., 1994; Mahadevan and Edwards, 1991;
Zinck et al., 1995). It is therefore conceivable that these
preexisting cellular proteins may participate in modification
of the newly translated ICP27 protein to create the unusual
immunoreactivity pattern observed in the presence of CHX.
Although this seems the most likely explanation, it must be
noted that in addition to the simple phosphorylation and
methylation described for ICP27, it has been reported that it
also possesses the more complex modification of nucleoti-
dylylation. Thus, studies such as simple phosphatase treat-
ment will not completely define the composition of the
putative modified structures. Further studies on the bio-
chemical nature of the three species are currently underway.
(iii) Low mobility ICP27 forms produced during the
course of productive wild-type HSV-1 infection appear to
comigrate with the ICP27 triplet species. In addition, triplet
forms were observed to comigrate with slower mobility
ICP27 bands following infection with six different recom-
binant viruses. During our time course studies, we observed
that the triplet entities were produced as early as 6 hpi.
When infection proceeded for 24 h, we were able to detect
the ICP27 triplet species when CHX was added at 3 hpi. In
both instances, we observed that in the absence of CHX the
63000 molecular weight ICP27 protein synthesized during
wild-type infection contained at least one faint slower-
migrating band that reacted with both the anti-ICP27
H1113 mAb and the pAb. Based on these findings, we
propose the hypothesis that the ICP27 triplet moieties are
present early during wild-type HSV-1 infection, but the later
synthesis of the 63000 molecular weight ICP27 protein
overshadows the faster-migrating forms of the triplet, thus
occluding their detection. In our ‘‘occlusion model’’, the
addition of CHX simply allows for the visualization of the
ICP27 triplet forms in a clear and unobscured fashion.
Although the necessity to use CHX to observe these species
is unfortunate, CHX has been consistently shown to be a
valuable tool for dissecting the regulatory events in HSV-1
gene expression (Elshiekh et al., 1991; Harris-Hamilton and
Bachenheimer, 1985; Honess and Roizman, 1974; Preston,
1979; Watson and Clements, 1980). Another intriguing
explanation for our findings is that the ICP27 protein may
be first synthesized in an unprocessed, bulkier form (the
triplets) that then becomes progressively ‘‘processed’’ by
viral or cellular proteins that act to ‘‘mature’’ ICP27 late in
infection. In the presence of CHX, such proteins might not
be produced, resulting in only the detection of the ‘‘imma-
ture’’ ICP27 triplet species. The three slow-migrating ICP27
entities discovered in this study may be important, albeit
still poorly understood, protein species that ultimatelycontribute to ICP27’s known regulatory functions during
HSV-1 infection.
(iv) ICP27 triplet is revealed when ribosomal peptidyl-
tRNA translocation is inhibited during infection. Following
HSV-1 infection in the presence of PUR, the ICP27 protein
moieties were not observed, yet the addition of CHX in
conjunction with PUR enabled their generation. The expla-
nation for this observation and CHX’s apparent dominant
effect over PUR can be explained by looking at the modes
of action of these two inhibitors (Baliga et al., 1970). CHX
inhibits the translocation of peptidyl-tRNA from the amino-
acyl (A) site to the peptidyl (P) site on the ribosome (Baliga
et al., 1969). In contrast, PUR is similar in structure to
aminoacyl-tRNA and upon its incorporation into the grow-
ing polypeptide chain, results in the premature release of
nascent proteins from ribosomes (Allen and Zamecnik,
1962; Morris and Schweet, 1961). Formation of peptidyl-
puromycin is catalyzed by the peptidyl-transferase activity
of the 60S ribosomal subunit only when PUR is in the P
position on the ribosome (Traut and Monro, 1964). It has
been shown that CHX inhibits the reaction of PUR with
peptidyl-tRNA in the A position (Baliga et al., 1970), thus
rendering simultaneous treatment with PUR ineffective.
Thus, CHX exerts a dominant effect. One potential conse-
quence of this CHX treatment could be that the triplet forms
of ICP27 might contain bound tRNA. Studies designed to
detect such modifications, if any, present in these protein
moieties should help clarify this issue. In an attempt to
follow the stability of the ICP27 triplet, we performed pulse-
chase experiments using radiolabeled amino acids (data not
shown). Unfortunately, adequate levels of labeled ICP27
could not be detected, even in the absence of CHX,
consistent with earlier studies (Blaho et al., 1993). These
studies, however, turned out to be an important control.
Essentially, no new radiolabel incorporation into polypep-
tides was detected in the CHX-treated samples, confirming
general translation inhibition. This result was actually not
surprising because we never detected immunostaining of
any of the representative (non-ICP27) viral proteins in the
presence of CHX. Of course, because it appears to us that
only ICP27 triplets are produced under these conditions,
peptidyl-tRNA translocation is not completely inhibited.
Perhaps the most puzzling piece of our current data is
simply the finding that translation of a subset of ICP27
species can occur in the presence of CHX. A similar
observation was found using Sendai virus where the CV
protein was stimulated in the presence of CHX, but not with
PUR or pactamycin, an inhibitor of chain initiation (Gupta
and Ono, 1997). We are currently testing whether the ICP27
forms are detected in the presence of pactamycin. Although
we have only looked at representative members of the other
kinetic classes of viral genes, including another IE protein,
ICP4, apparently this phenomenon may be unique to ICP27.
One possible explanation for this result may be that an
unusual characteristic of the ICP27 mRNA exists that
enables its translation upon CHX treatment. It is also
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through activation of an endogenous cellular protein or an
incoming viral tegument protein that is able to compensate
for the translocase function of the 60S ribosomal subunit
inhibited by CHX. Such a hypothesis is supported by our
data showing faint but detectable ICP27 species in unin-
fected 2.2 cells without CHX, but not in its presence. This
suggests that virus infection is required to produce the forms
when ribosomal aminoacyl-tRNA translocation is blocked.
Further studies are needed to identify this putative infected
factor(s).
We speculate that some unique feature of the ICP27
transcript allows for its translation when ribosomal peptidyl-
tRNA translocation is inhibited. Because ICP27 is known to
participate in the shutoff of host cell protein synthesis by
inhibiting the splicing of host pre-mRNAs (Hardy and
Sandri-Goldin, 1994), it is conceivable that HSV-1 may
have evolved a mechanism to translate these important
ICP27 protein species in spite of the gross cessation of
translation that occurs immediately upon infection. Consid-
eration of these findings would be beneficial to those
characterizing the HSV-1 ICP27 protein because these
immunoreactive species may be relevant to its regulatory
functions during the course of viral infection.Materials and methods
Cells and viruses
All cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) containing 5% fetal bovine serum (FBS).
Human epithelial (HEp-2) and monkey kidney (Vero) cells
were obtained from the American Type Culture Collection
(Rockville, Md.). HSV-1(F) was obtained from Bernard
Roizman (University of Chicago). Vero 2.2 cells, HSV-
1(KOS1.1), and HSV-1(vBSD27) were generously provided
by Saul Silverstein (Columbia University). Vero 2.2 is a
derivative Vero cell line expressing ICP27 under its own
promoter (Sekulovich et al., 1988). F and KOS1.1 are the
wild-type HSV-1 strains used in this study. vBSD27 (Soli-
man et al., 1997) is the KOS1.1-derived ICP27-null mutant
virus used in this analysis. It contains a replacement of the
a27 gene with the Escherichia coli lacZ gene and therefore
must be propagated and titered on an ICP27-complementing
cell line, such as Vero 2.2 (Sekulovich et al., 1988). d3–4,
d4–5, d5–6, d6–7, n263R, and n406R are recombinant
ICP27-mutant viruses (Aubert et al., 2001; Mears and Rice,
1996; Mears et al., 1995; Rice and Knipe, 1990) that were
generously provided by Steve Rice (University of Minne-
sota). HSV-1(V422) was generously provided by James R.
Smiley (University of Alberta, Canada) and contains a
truncation of the C-terminal transcriptional activation do-
main of VP16 at amino acid 422 (Lam et al., 1996). V422
was propagated and titered on Vero cells in the presence of 3
mM hexamethylene bisacetamide (HMBA; Sigma) as de-scribed previously (Smiley and Duncan, 1997). All viral
titers were determined at 48 hpi by standard dilution
techniques on Vero or Vero 2.2 cells and all values are the
mean of duplicate infections. Unless otherwise specified,
cell monolayers were infected at a multiplicity of infection
(MOI) of 5 plaque forming units (PFU) per cell and the
infections were maintained at 37 jC in DMEM containing
5% newborn calf serum (NBCS) for the times indicated in
the text. All tissue culture reagents were purchased from
Life Technologies.
Maintenance of infected cells in the presence of drugs
Unless otherwise specified, cycloheximide (CHX; Sig-
ma) was added to the medium of cell monolayers at a final
concentration of 10 Ag/ml, an amount previously shown to
efficiently inhibit de novo protein synthesis in HSV-1-
infected HEp-2 cells (Aubert and Blaho, 1999). Cells were
pretreated with CHX for 1 h at 37 jC before infection unless
otherwise stated, and CHX was maintained in the medium
until protein extraction procedures were performed. Actino-
mycin D (Act. D; Sigma) was dissolved in dimethylsulf-
oxide (DMSO; Sigma) to make a 1 mg/ml stock solution for
use in transcription inhibition studies. Act. D was then
added to the medium of HEp-2 monolayers at a final
concentrations of 125 ng/ml, an amount previously shown
to completely inhibit ICP4 synthesis (Sanfilippo et al.,
2004). Cells were pretreated with either Act. D or equal
volumes of DMSO (125 nl/ml) for 1 h at 37 jC before HSV-
1 infection, and both Act. D and DMSO were maintained in
the medium until protein extraction procedures were per-
formed. In order to compensate for the absence of the VP16
transcriptional activation domain, HMBA was added to the
medium of cell monolayers (final concentration of 3 mM) at
the time of infection, as shown previously (McFarlane et al.,
1992; Smiley and Duncan, 1997), and was maintained in the
medium until protein extraction procedures were performed.
To inhibit de novo protein synthesis, puromycin (PUR;
Sigma) was added to the medium of cell monolayers at
final concentrations of either 0.5 or 1 Ag/ml. Cells were
pretreated with PUR for 1 h at 37 jC before infection and
PUR was maintained in the medium until protein extraction
procedures were performed.
UV treatment of virus
UV-inactivated virus stocks were generated as described
previously (Sanfilippo et al., 2004). Briefly, HSV-
1(KOS1.1) virus (109 PFU) in a final volume of 2 ml of
199 V containing 1% FBS was placed in a 10-mm-diameter
dish on ice, 10 cm from a germicidal lamp, and exposed to
UV light for 4 min with mixing at 2 min. After removal of
100 Al for titering purposes, the UV-treated mixture was
then divided into aliquots and stored at 80 jC until use.
Virus aliquot volumes were calculated based the amount of
virus necessary for an MOI of 20 PFU/cell before UV
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cell) were determined on Vero cells.
Infected cell extract preparation, denaturing gel
electrophoresis, and transblotting
Whole extracts of infected cells were obtained as de-
scribed previously (Sanfilippo et al., 2004). The protein
concentrations of all cell extracts were determined by a
modified Bradford assay (Bio-Rad) as recommended by the
vendor. Equal amounts of infected cell proteins (50 Ag) were
separated in denaturing 12% or 15% N,NV-diallyltartardia-
mide-acrylamide gels (Blaho and Roizman, 1998) and
electrically transferred to nitrocellulose membranes in a tank
apparatus (Bio-Rad) before immunoblotting with various
primary antibodies. Unless otherwise noted in the text, all
biochemical reagents were obtained from Sigma. Nitrocel-
lulose was obtained directly from Schleicher and Schuell.
Prestained protein molecular weight markers (not shown in
figures) were purchased from Life Technologies and Bio-
Rad. Immunoblots were digitized (600–800 dpi) with an
AGFA Arcus II scanner linked to a Macintosh G3 Power PC
workstation. Raw digital images were saved as tagged
image files (TIF) with Adobe Photoshop and organized into
figures with Adobe Illustrator.
Immunological reagents
The following primary antibodies were used to detect
viral proteins: (i) H1113, mouse anti-ICP27 monoclonal
antibody (mAb), specific for the internal NLS mapping to
residues 110–137 (Mears et al., 1995); (ii) H1119, mouse
anti-ICP27 mAb, specific for the N-terminal 11 residues
(Mears et al., 1995; Upton et al., 1994); (iii) H1114, mouse
anti-ICP4 mAb; (iv) H1104, mouse anti-gC mAb; (v)
RGST49, rabbit polyclonal antibody (pAb) directed against
a GST-VP22 fusion protein (48); (vi) rabbit anti-ICP27 pAb
(gift of S. Silverstein, Columbia University). All mAbs were
purchased from Goodwin Institute for Cancer Research
(Plantation, FL). Secondary goat anti-rabbit and goat anti-
mouse antibodies conjugated with alkaline phosphatase
were purchased from Southern Biotechnology (Birming-
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